Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6996806 | 0.89 | ALDH1A1 (0.53) | ATMMAPTRXFP1ALOX5ALDH1A1 | |
| SCHEMBL7002378 | 0.87 | PKM (0.47) | MAPTALOX5ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL6996551 | 0.83 | ALDH1A1 (0.45) | MAPTRXFP1ALOX5ALDH1A1SMN1; SMN2 | |
| SCHEMBL8113447 | 0.81 | ALDH1A1 (0.43) | ATMMAPTRXFP1ALOX5ALDH1A1 | |
| SCHEMBL5670589 | 0.72 | AHR (0.39) | MAPTALDH1A1SMN1; SMN2HTR7HTR2B | |
| SCHEMBL6996657 | 0.71 | SLC6A4 (0.35) | — | |
| SCHEMBL10652999 | 0.71 | MAPT (0.78) | MAPTRXFP1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL6992556 | 0.71 | ALOX5 (0.49) | MAPTALOX5ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL6992552 | 0.71 | ALOX5 (0.49) | MAPTALOX5ALDH1A1SMN1; SMN2KDM4E | |
| Hydrochloric Acid SCHEMBL5672533 | 0.71 | AHR (0.38) | MAPTSMN1; SMN2HTR7HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1015437-B1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 2003-12-03 | — | — | EP | disclosed |
| US-6365736-B1 | TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-1015437-A1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999012915-A1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-03-18 | — | — | WO | disclosed |